Denali Therapeutics Stock Price History

DNLI Stock  USD 14.61  0.21  1.42%   
Below is the normalized historical share price chart for Denali Therapeutics extending back to December 08, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Denali Therapeutics stands at 14.61, as last reported on the 21st of March, with the highest price reaching 14.61 and the lowest price hitting 14.61 during the day.
IPO Date
8th of December 2017
200 Day MA
23.4643
50 Day MA
19.9926
Beta
1.458
 
Covid
If you're considering investing in Denali Stock, it is important to understand the factors that can impact its price. Denali Therapeutics secures Sharpe Ratio (or Efficiency) of -0.11, which denotes the company had a -0.11 % return per unit of risk over the last 3 months. Denali Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Denali Therapeutics' Variance of 19.74, mean deviation of 3.32, and Standard Deviation of 4.44 to check the risk estimate we provide.
  
The Denali Therapeutics' current Other Stockholder Equity is estimated to increase to about 2.9 B, while Total Stockholder Equity is projected to decrease to under 776.9 M. . The current Price To Sales Ratio is estimated to decrease to 9.74. The Denali Therapeutics' current Price Earnings Ratio is estimated to increase to -7.53. Denali Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1072

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsDNLI

Estimated Market Risk

 4.58
  actual daily
40
60% of assets are more volatile

Expected Return

 -0.49
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Denali Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Denali Therapeutics by adding Denali Therapeutics to a well-diversified portfolio.
Price Book
1.7135
Enterprise Value Ebitda
(8.66)
Price Sales
3.6 K
Shares Float
131.3 M
Wall Street Target Price
36.625

Denali Therapeutics Stock Price History Chart

There are several ways to analyze Denali Stock price data. The simplest method is using a basic Denali candlestick price chart, which shows Denali Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 5, 202523.59
Lowest PriceMarch 18, 202514.51

Denali Therapeutics March 21, 2025 Stock Price Synopsis

Various analyses of Denali Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Denali Stock. It can be used to describe the percentage change in the price of Denali Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Denali Stock.
Denali Therapeutics Price Rate Of Daily Change 0.99 
Denali Therapeutics Price Action Indicator(0.11)

Denali Therapeutics March 21, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Denali Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Denali Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Denali Stock and then apply it to test your longer-term investment strategies against Denali.

Denali Stock Price History Data

The price series of Denali Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 9.36 with a coefficient of variation of 13.82. Under current investment horizon, the daily prices are spread out with arithmetic mean of 20.31. The median price for the last 90 days is 21.25.
OpenHighLowCloseVolume
03/21/2025
 14.82  14.61  14.61  14.61 
03/21/2025
 14.82  15.03  14.41  14.61 
03/19/2025 14.45  15.03  14.41  14.82  683,596 
03/18/2025 15.24  15.24  14.49  14.51  814,434 
03/17/2025 15.15  15.68  14.88  15.44  576,435 
03/14/2025 15.09  15.70  14.99  15.15  922,545 
03/13/2025 15.86  16.16  14.78  14.89  670,750 
03/12/2025 15.21  16.28  15.10  15.95  2,062,316 
03/11/2025 14.95  15.16  14.20  15.04  1,753,690 
03/10/2025 16.36  16.53  14.88  14.95  1,740,823 
03/07/2025 16.34  16.97  16.11  16.69  1,620,980 
03/06/2025 15.61  16.35  15.21  16.27  1,714,903 
03/05/2025 16.06  16.42  15.65  16.30  1,323,303 
03/04/2025 15.10  16.50  14.01  15.95  2,814,720 
03/03/2025 16.36  16.79  15.11  15.20  2,262,750 
02/28/2025 18.83  19.00  16.32  16.56  2,218,032 
02/27/2025 19.13  19.52  18.40  18.60  816,092 
02/26/2025 19.31  19.66  18.67  18.89  724,780 
02/25/2025 20.83  20.83  18.95  19.20  987,762 
02/24/2025 20.96  20.96  20.22  20.67  777,322 
02/21/2025 22.00  22.05  20.68  20.73  831,159 
02/20/2025 22.20  22.81  21.50  21.59  784,124 
02/19/2025 21.62  22.27  21.33  22.23  587,405 
02/18/2025 21.52  22.27  21.38  21.79  730,468 
02/14/2025 21.50  22.29  21.23  21.37  780,740 
02/13/2025 21.19  21.54  20.65  21.31  579,938 
02/12/2025 20.13  21.03  20.05  20.82  747,279 
02/11/2025 21.48  21.51  20.17  20.58  1,059,565 
02/10/2025 22.32  22.34  20.22  20.88  1,049,061 
02/07/2025 22.41  23.04  22.11  22.25  817,231 
02/06/2025 23.73  23.79  22.50  22.53  908,623 
02/05/2025 23.30  24.35  22.73  23.59  1,045,934 
02/04/2025 21.80  23.51  21.76  22.99  865,576 
02/03/2025 22.45  22.86  21.55  21.84  956,770 
01/31/2025 23.37  23.81  22.73  23.30  1,101,245 
01/30/2025 23.64  24.29  23.45  23.58  803,363 
01/29/2025 23.35  23.79  23.15  23.41  585,834 
01/28/2025 23.18  23.52  22.54  23.50  625,149 
01/27/2025 22.02  23.20  21.85  23.19  981,025 
01/24/2025 23.12  23.36  22.11  22.22  861,092 
01/23/2025 22.96  23.35  22.35  23.28  919,691 
01/22/2025 23.04  23.69  22.72  23.31  1,025,558 
01/21/2025 22.21  23.33  22.05  23.04  1,000,960 
01/17/2025 21.94  22.27  21.47  21.93  868,178 
01/16/2025 21.55  22.37  21.05  21.67  1,302,562 
01/15/2025 19.64  22.02  19.45  21.50  1,693,340 
01/14/2025 19.85  19.90  18.52  18.74  985,565 
01/13/2025 19.01  19.65  18.65  19.59  840,466 
01/10/2025 20.46  20.80  18.67  19.10  1,302,440 
01/08/2025 21.19  21.83  21.10  21.25  1,245,656 
01/07/2025 18.75  21.61  18.69  21.18  1,660,734 
01/06/2025 21.10  21.39  19.73  19.82  1,621,223 
01/03/2025 21.20  21.56  20.96  21.26  642,314 
01/02/2025 20.73  21.18  20.45  20.84  698,526 
12/31/2024 20.41  20.80  20.06  20.38  494,457 
12/30/2024 20.45  20.51  19.93  20.24  862,895 
12/27/2024 21.06  21.63  20.50  20.61  602,337 
12/26/2024 20.71  21.64  20.50  21.32  525,121 
12/24/2024 20.75  21.07  20.49  20.92  265,790 
12/23/2024 21.24  21.44  20.50  20.78  1,023,246 
12/20/2024 21.36  22.21  21.00  21.45  2,810,606 

About Denali Therapeutics Stock history

Denali Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Denali is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Denali Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Denali Therapeutics stock prices may prove useful in developing a viable investing in Denali Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding164.5 M96.2 M
Net Loss-293.4 M-278.7 M

Denali Therapeutics Quarterly Net Working Capital

762.23 Million

Denali Therapeutics Stock Technical Analysis

Denali Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Denali Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Denali Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

Denali Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Denali Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Denali Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Denali to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Denali Stock analysis

When running Denali Therapeutics' price analysis, check to measure Denali Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Denali Therapeutics is operating at the current time. Most of Denali Therapeutics' value examination focuses on studying past and present price action to predict the probability of Denali Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Denali Therapeutics' price. Additionally, you may evaluate how the addition of Denali Therapeutics to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Correlations
Find global opportunities by holding instruments from different markets